Chemoinformaics analysis of Methyl 2-methylhexacosanoate
| Molecular Weight | 424.754 | nRot | 24 |
| Heavy Atom Molecular Weight | 368.306 | nRig | 24 |
| Exact Molecular Weight | 424.428 | nRing | 0 |
| Solubility: LogS | -3.448 | nHRing | 0 |
| Solubility: LogP | 1.94 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 85.7044 |
| nHD | 0 | BPOL | 58.7836 |
| QED | 0.811 |
| Synth | 5.844 |
| Natural Product Likeliness | 1.808 |
| NR-PPAR-gamma | 0.184 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.063 |
| Pgp-sub | 0.527 |
| HIA | 0.008 |
| CACO-2 | -5.008 |
| MDCK | 0.0000225 |
| BBB | 0.993 |
| PPB | 0.436098 |
| VDSS | 6 |
| FU | 0.549147 |
| CYP1A2-inh | 0.05 |
| CYP1A2-sub | 0.198 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.927 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.104 |
| CYP2d6-inh | 0.775 |
| CYP2d6-sub | 0.89 |
| CYP3a4-inh | 0.245 |
| CYP3a4-sub | 0.784 |
| CL | 5.17 |
| T12 | 0.07 |
| hERG | 0.341 |
| Ames | 0.256 |
| ROA | 0.874 |
| SkinSen | 0.226 |
| Carcinogencity | 0.933 |
| EI | 0.011 |
| Respiratory | 0.984 |
| NR-Aromatase | 0.878 |
| Antiviral | Yes |
| Prediction | 0.523485 |